Lupin Ltd. Company News

You can view the latest news of the Company.

Select Another Company

Market Cap. (Rs.) 90763.21 Cr. P/BV 5.28 Book Value (Rs.) 376.64 52 Week High/Low (Rs.) 2403/1795 FV/ML 2/1 P/E(X) 27.66 Bookclosure 25/07/2025 EPS (Rs.) 71.85 Div Yield (%) 0.60 Date and Time Headlines 31/10/2025 18:18 Lupin Ltd. - Copy of Newspaper Publication 30/10/2025 13:55 Lupin Digital Health Launches VITALYFE™, an AI-Powered Cardio... 30/10/2025 13:53 Lupin Ltd. - Press Release 30/10/2025 13:52 Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release ... 28/10/2025 15:55 Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release ... 28/10/2025 15:52 Lupin Ltd. - Press Release 28/10/2025 15:41 Lupin Ltd. - Announcement under Regulation 30 (LODR)-Allotment of E... 28/10/2025 15:39 Lupin Ltd. - ESOP/ESOS/ESPS 27/10/2025 18:02 Lupin Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Inve... 27/10/2025 17:53 Lupin Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates 24/10/2025 11:15 Lupin launches Authorized Generic of Ravicti® in the U.S. Market 24/10/2025 09:37 Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release ... 24/10/2025 09:33 Lupin Ltd. - Press Release 22/10/2025 16:25 Lupin Ltd. - Board Meeting Intimation for Considering And Taking On... 17/10/2025 16:30 Lupin Ltd. has submitted to BSE the Shareholding Pattern for the Pe... 13/10/2025 17:09 Lupin to Present Phase 1 Data on LNP3693 at ESMO Congress 2025 13/10/2025 14:49 Lupin Ltd. - Press Release 13/10/2025 14:48 Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release ... 11/10/2025 12:10 Lupin Ltd. - U.S. FDA Has Conducted A Pre-Approval Inspection At Th... 11/10/2025 12:10 Lupin Ltd. - U.S. FDA Has Conducted A Pre-Approval Inspection At Th... 1 2